好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Peripheral Nerve: Molecular Mechanisms of Peripheral Neuropathy

Thursday 04/15/10
01:15 PM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Peripheral Nerve, Neurogenetics and Gene Therapy
No CME available
Event Timeline
01:15 PM - 02:30 PM Abstract 001 - Oral Curcumin Treatment Partially Mitigates the Phenotype of the R98C Knock-In Mouse Model of CMT1B
01:15 PM - 02:30 PM Abstract 002 - Spontaneous Demyelinating Autoimmune Neuropathy in ICAM-1 Deficient NOD Mice
01:15 PM - 02:30 PM Abstract 003 - Unfolded Protein Response (UPR) Activation in a Mouse Model of Early-Onset CMT 1B
01:15 PM - 02:30 PM Abstract 004 - Distinct Pathogenic Processes between Fig4-Deficient Sensory and Motor Neurons
01:15 PM - 02:30 PM Abstract 005 - NT-3 Gene Therapy Improves Compound Muscle Action Potential (CMAP) and Function in Mouse Model for Charcot-Marie-Tooth (CMT) Neuropathy
Faculty Disclosures
Ahmet Hoke, MD, PhD, FAAN Dr. Hoke has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm. Dr. Hoke has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Clinical and Translational Neurology. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burke and Thomas. Dr. Hoke has received stock or an ownership interest from Axoprotego Therapeutics. The institution of Dr. Hoke has received research support from NIH. The institution of Dr. Hoke has received research support from DOD. The institution of Dr. Hoke has received research support from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. The institution of Dr. Hoke has received research support from Foundation for Peripheral Neuropathy. Dr. Hoke has received intellectual property interests from a discovery or technology relating to health care.
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Mario A. Saporta, MD, PhD, FAAN Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics.
No disclosure on file
Istvan Katona No disclosure on file
Jun Li, MD, PhD, FAAN The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Michael E. Shy, MD, FAAN Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Christopher Edwards No disclosure on file
Zarife Sahenk, MD, PhD, FAAN Dr. Sahenk has nothing to disclose.
Agnes Jani-Acsadi, MD No disclosure on file
Agnes Patzko, MD No disclosure on file
Lawrence G. Wrabetz, MD No disclosure on file
Gerd Meyer Zu Horste, MD Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant, Roche. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen, Alexion. The institution of Dr. Meyer Zu Horste has received research support from Merck KGaA. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Brian Shy No disclosure on file
Gloria Galloway, MD, FAAN No disclosure on file
TURAN DOGAN, MD No disclosure on file
John W. Cochran, MD No disclosure on file